Catalyst Pharmaceuticals Inc (CPRX)
16.18
+0.06
(+0.40%)
USD |
NASDAQ |
May 31, 16:00
16.37
+0.20
(+1.21%)
After-Hours: 20:00
Catalyst Pharmaceuticals Gross Profit Margin (Quarterly): 87.29% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 87.29% |
December 31, 2023 | 85.70% |
September 30, 2023 | 86.20% |
June 30, 2023 | 87.90% |
March 31, 2023 | 88.35% |
December 31, 2022 | 81.57% |
September 30, 2022 | 83.12% |
June 30, 2022 | 85.61% |
March 31, 2022 | 86.33% |
December 31, 2021 | 80.82% |
September 30, 2021 | 85.23% |
Date | Value |
---|---|
June 30, 2021 | 87.50% |
March 31, 2021 | 84.50% |
December 31, 2020 | 84.30% |
September 30, 2020 | 86.77% |
June 30, 2020 | 86.02% |
March 31, 2020 | 85.75% |
December 31, 2019 | 85.40% |
September 30, 2019 | 85.80% |
June 30, 2019 | 85.22% |
March 31, 2019 | 86.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.82%
Minimum
Dec 2021
88.35%
Maximum
Mar 2023
85.47%
Average
85.73%
Median
Gross Profit Margin (Quarterly) Benchmarks
Pfizer Inc | 77.29% |
Sarepta Therapeutics Inc | 87.77% |
PTC Therapeutics Inc | 92.98% |
Corcept Therapeutics Inc | 98.27% |
Cytokinetics Inc | -9.67K% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 16.22% |
Return on Assets | 13.67% |
Return on Invested Capital | 16.22% |
Profit Margin (Quarterly) | 23.63% |
Operating Margin (Quarterly) | 27.54% |
Return on Net Operating Assets | 25.38% |